All News

Top news of the day from across the health care landscape.

The recommendation means more men could be screened, now that the recommendation has been upgraded from its existing D recommendation to a grade C recommendation.

Lofexidine (LUCEMYRA) safely reduces opioid withdrawal symptoms at 3.2 mg/day and 2.4 mg/day to a clinically meaningful extent, facilitating opioid discontinuation treatment, according to data from a pooled analysis.

Top news of the week from Specialty Pharmacy Times.

We talk about how to get help if you are a pharmacist struggling with substance use disorder.

Researchers found that women with advanced triple-negative breast cancer who had inherited a BRCA mutation benefited more from the chemotherapy carboplatin than standard treatment.

Use your free time wisely, and land your dream job by becoming a more competitive candidate.

Samm Anderegg blends pharmacy, technology, and entrepreneurship to leave traditional pharmacy, and start his own business.

A new study examines how chemoresistance evolves over time, which could lead to improved patient outcomes and survival.

The utility of determining a patient's asthma phenotype is a current research priority, since various phenotypes seem to respond differently to interventions and medication.

CMS released its first strategy to address rural health care, saying that it wants people who live in rural America to “have access to high quality, affordable healthcare.”

Adults that use marijuana and cocaine generally experience the worst possible outcomes of a myocardial infarction (MI), according to a recent study.

According to the case study, an acute myeloid leukemia patient has remained cancer free for 9 months following treatment with the chimeric antigen receptor (CAR) T-cell treatment, CYAD-01, and a bone marrow transplant.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Text messages proactively gauge patients' struggle with opioid addiction to prevent relapse.

The agency recently said that it plans to be more proactive in this space, what the health care industry has been slow to adapt.

This adult fantasy game provides a first-hand view of psychosis and the symptoms its patients often experience.

The Conference on Retroviruses and Opportunistic Infections (CROI) annually assembles researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS, and related infectious diseases.

Multiple companies are looking into using smartphones to track patients taking their medications. Who is involved, and what may happen in the future?

A dual immune-checkpoint blockade efficiently controlled the development of chronic lymphocytic leukemia by restoring functional antitumor immune response.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

More US adults believe that it is easy to get access to opioids for unlawful use, with millennials believing this more so than baby boomers.

Treatment with RBP-7000 significantly reduced Positive and Negative Syndrome Scale (PANSS) total score and greatly increased the percentage of adults with schizophrenia achieving treatment response.

Rates of hospital inpatient admissions before and during use of ivacaftor found that overall and cystic fibrosis-related inpatient admissions fell by 55% and 81%, respectively.

The development and uptake of antiretroviral therapy for HIV has reduced the risk of certain cancers were previously prevalent.

What qualities do your pharmacist colleagues feel are most important to succeed as a new pharmacist?

A recent study highlights the decline in overdoses related to buprenorphine after the use of UDP, but should it be expanded?

The results of the company's recent research highlight nonadherence and bring to mind novel ways to address a national problem.